CANNABIDIOL A THERAPEUTIC POTENTIAL IN THE TREATMENT OF EPILEPSY AND ITS MECHANISMS OF ACTION: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.31692/2764-3433.v5i1.298Keywords:
Keywords: cannabidiol; epilepsy; CB1 receptors; endocannabinoid system; seizures.Abstract
Introduction: Cannabidiol (CBD), a non-psychoactive compound from Cannabis sativa, is studied for its therapeutic potential, particularly in neurological disorders like epilepsy. Objectives:Analyze the mechanisms of CBD action in brain cells of individuals with epilepsy, focusing on the involved signaling pathways. Methodology: A systematic review was conducted using “Cannabidiol” and “Epilepsy” in PubMed, Scopus, and SciELO (2019–2024), selecting ten articles. Results: CBD may reduce seizures, especially in refractory cases, by interacting with the endocannabinoid system and modulating CB1 and CB2 receptors. Further research is needed to clarify its mechanisms. Conclusion: CBD shows promising therapeutic effects in epilepsy, but further research is essential to optimize its clinical use.

Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.